Cytodyn Inc.

Biotechnology • Healthcare • Vancouver, WA, United States • CYDY (OQB)

CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.

360 980 8524 1111 Main Street, Vancouver, WA 98660, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

CytoDyn Secures $30 Million Commitment from Yorkville Advisors - CytoDyn Inc.

CytoDyn Inc. • Nov 3

CytoDyn (CYDY) sets 2026 CRC, mTNBC Phase 2 plans after leronlimab survival data - Stock Titan

Stock Titan • Dec 16

CytoDyn must face investor lawsuit alleging misleading claims in COVID, HIV drug debacle - Fierce Biotech

Fierce Biotech • Jun 27

Judge Criticizes Push For Harsher Sentence In CytoDyn Case - Law360

Law360 • Sep 26

Halper Sadeh LLC Encourages CytoDyn Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire

Business Wire • Oct 22

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has CytoDyn Inc. had layoffs?

No layoff events have been recorded for CytoDyn Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does CytoDyn Inc. have?

CytoDyn Inc. has approximately 13 employees.

What industry is CytoDyn Inc. in?

CytoDyn Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is CytoDyn Inc. a publicly traded company?

Yes, CytoDyn Inc. is publicly traded under the ticker symbol CYDY on the OQB. The company has a market capitalization of approximately $0.35 billion.

Where is CytoDyn Inc. headquartered?

CytoDyn Inc. is headquartered in Vancouver, WA, United States at 1111 Main Street, Vancouver, WA 98660, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.